Tag
Robert A. Bradway
2 articles
Amgen Q1 Earnings Beat, R&D Up 16%
Amgen posted Q1 adjusted EPS of $5.15, beating consensus $4.80, and revenue of $8.62 bn, up 6% YoY.
FY2026 guidance targets EPS $21.70‑$23.10 (mid $22.40) and revenue $37.1‑$38.5 bn (mid $37.8 bn), ne
Amgen Q1 EPS Beats, Revenue Up 6%
Amgen reported adjusted EPS of $5.15, topping consensus $4.80 by $0.35.
Revenue reached $8.62 billion, slightly above $8.59 billion estimate and up 6% YoY from $8.15 billion in Q1 2025.
R&D expenses r